Company intelligence / Profile preview

Inceptua

Luxembourg, Luxembourg

Ownership: Private
Employees: ~120
Development stage: Other

Overview

Inceptua is a global pharmaceutical services and specialty pharma company founded in 1997, providing clinical trial supply, early/managed access, and commercialization for orphan and specialty medicines, including licensed products such as paclitaxel micellar (Apealea) and ocriplasmin (Jetrea), and numerous pre‑approval and unlicensed medicines access programs worldwide.[1][4][6][7][8]

Therapeutic areas: OncologyOphthalmologyRare Diseases
Modalities: Small moleculeBiologicMonoclonal antibodyProteinVaccine
Industry: Biotech

Partnerships

Elevar Therapeutics – licensing and commercialization agreement for paclitaxel micellar (Apealea) in Europe[8]Onconova Therapeutics – pre‑approval access collaboration for rigosertib in selected countries outside the US[8]

Beyond the preview

Go deeper on Inceptua.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inceptua.

Explore the full profile